Clarify CACNA1A
Welcome to the CACNA1A Foundation blog: updates on current research, advocacy efforts,
therapy options, community activities and real life experiences of caregivers.
Lay Summary of the September 2022 Research Roundtable
The CACNA1A Foundation hosted its first Research Roundtable: Collaborating to Accelerate the Path to CACNA1A Clinical Trials on September 22nd and 23rd at the New York Academy of Medicine in New York City. It was a historic event with 37 of the world's experts on CACNA1A, ion channels, genetics, ataxia, epilepsy, hemiplegic migraine, and eye movement disorders convening for the first time ever. Goals included identifying gaps in understanding how CACNA1A variants lead to disease and developing therapeutic treatments that will have the greatest impact on those living with CACNA1A-related disorders.
The two-day conference was divided into three sessions, each with four presentations, followed by a facilitated discussion. The meeting closed with a wrap-up session focused on next steps for the CACNA1A Foundation and the CACNA1A Research Network to move treatments into the clinical trial pipeline. Read on for a summary of the presentations.